0
"Allogene Therapeutics began trading on the Nasdaq Stock Exchange today under the ALLO ticker. The price was at the top of its range, $18 per share. The company plans to raise $288 million with the sale of about 16 million shares".
https://www.biospace.com/article/focused-on-off-the-shelf-car-t-allogene-therapeutics-hits-the-nasdaq-at-18-per-share/
https://www.biospace.com/article/focused-on-off-the-shelf-car-t-allogene-therapeutics-hits-the-nasdaq-at-18-per-share/
